In an article titled “Reslizumab performance tied to eosinophil count,” published October 17, 2016, the frequency of infusions was misstated. Study participants were randomized to infusions of reslizumab 3.0 mg/kg or placebo given once every 4 weeks for 16 weeks.

Ads

You May Also Like

Inaccurate depictions of inpatient psychiatry foster stigma

When it comes to the portrayal of physicians in popular culture, psychiatrists are second ...